Edition:
United Kingdom

VBI Vaccines Inc (VBIV.OQ)

VBIV.OQ on NASDAQ Stock Exchange Capital Market

2.17USD
16 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.17
Open
$2.09
Day's High
$2.30
Day's Low
$2.07
Volume
21,887
Avg. Vol
88,615
52-wk High
$5.10
52-wk Low
$1.69

Chart for

About

VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity.... (more)

Overall

Beta: 1.55
Market Cap(Mil.): $156.09
Shares Outstanding(Mil.): 40.23
Dividend: --
Yield (%): --

Financials

  VBIV.OQ Industry Sector
P/E (TTM): -- 86.20 32.69
EPS (TTM): -0.87 -- --
ROI: -38.92 0.73 14.32
ROE: -42.80 1.82 16.04

BRIEF-VBI Vaccines Announces Positive Final Phase 1 Study Results Of Preventative CMV Vaccine

* VBI VACCINES ANNOUNCES POSITIVE FINAL PHASE 1 STUDY RESULTS OF PREVENTATIVE CMV VACCINE

10 May 2018

BRIEF- Vaccines Posts Q1 Loss Per Share $0.19

* VBI VACCINES ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

01 May 2018

BRIEF-VBI Vaccines Posts Positive DSMB Review Of Recurrent Glioblastoma Study

* VBI VACCINES ANNOUNCES POSITIVE DSMB REVIEW IN PHASE 1/2A STUDY OF VBI-1901 IN RECURRENT GLIOBLASTOMA (GBM) PATIENTS

17 Apr 2018

Earnings vs. Estimates